C$0.21 0.0 0.0%
Last Trade - 10/05/21
| Market Cap | £9.46m |
| Enterprise Value | £10.3m |
| Revenue | £112k |
| Position in Universe | 1726th / 2705 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 29th Feb | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.10 | 9.60 | 16.3 | |||
| +300 | ||||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Rapid Dose Therapeutics Corp is a Canada-based pharma-technology company. The Company offers drug delivery solutions. It offers over-the-counter and pharmaceutical drug delivery solutions. QuickStrip is its processed oral film that contains the active molecule embedded in the delivery matrix. QuickStrip is designed as an oral fast-dissolving drug delivery system, which releases pharmaceuticals, micronized oils, and a host of over-the-counter medicines. RDMx mixture is its formulation that is designed as an orally administrable composition comprising a film forming agent that is used to deliver a micronized therapeutic. Its QuickStrip Energy product delivers energizing caffeine. Its QuickStrip B12 product delivers vitamin B12 to user’s system, assisting with metabolism and physical energy. Melatonin is its QuickStrip Sleep product that delivers melatonin to the user’s system.
| Last Annual | February 29th, 2020 |
| Last Interim | November 30th, 2020 |
| Incorporated | February 27, 2008 |
| Public Since | December 17, 2018 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | Canadian Securities Exchange |
| Shares in Issue | 77,067,435 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 1121 Walkers Line Unit 3, BURLINGTON, L7N 2G4, Canada |
| Web | |
| Phone | +1 416 5096509 |
| Auditors | MNP LLP |
As of 10/05/21, shares in Rapid Dose Therapeutics are trading at C$0.21, giving the company a market capitalisation of £9.46m. This share price information is delayed by 15 minutes.
Shares in Rapid Dose Therapeutics are currently trading at C$0.21 and the price has moved by -16% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Rapid Dose Therapeutics price has moved by -35.44% over the past year.
There are no analysts currently covering Rapid Dose Therapeutics.
Rapid Dose Therapeutics is scheduled to issue upcoming financial results on the following dates:
Rapid Dose Therapeutics does not currently pay a dividend.
Rapid Dose Therapeutics does not currently pay a dividend.
Rapid Dose Therapeutics does not currently pay a dividend.
To buy shares in Rapid Dose Therapeutics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Rapid Dose Therapeutics are currently trading at C$0.21, giving the company a market capitalisation of £9.46m.
Here are the trading details for Rapid Dose Therapeutics:
Based on an overall assessment of its quality, value and momentum, Rapid Dose Therapeutics is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Rapid Dose Therapeutics are currently priced at C$0.21. At that level they are trading at 0.757% discount to the analyst consensus target price of 0.00.
Analysts covering Rapid Dose Therapeutics currently have a consensus Earnings Per Share (EPS) forecast of 0.01 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rapid Dose Therapeutics. Over the past six months, the relative strength of its shares against the market has been -45.19%. At the current price of C$0.21, shares in Rapid Dose Therapeutics are trading at -19.54% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Rapid Dose Therapeutics.
Rapid Dose Therapeutics's management team is headed by:
Here are the top five shareholders of Rapid Dose Therapeutics based on the size of their shareholding:
